Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Citi
Mallinckrodt
Accenture
Farmers Insurance
US Army
Cerilliant
Chinese Patent Office
US Department of Justice

Generated: August 19, 2017

DrugPatentWatch Database Preview

DOXORUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Doxorubicin Hydrochloride, and when can generic versions of Doxorubicin Hydrochloride launch?

Doxorubicin Hydrochloride is a drug marketed by Mylan Labs Ltd, Alvogen Inc, Sun Pharm Inds, West-ward Pharms Int, Actavis Inc, Pharmacia And Upjohn, Pharmachemie Bv, Teva Pharms Usa, Sandoz Inc, Fresenius Kabi Usa, Amneal Pharms Co, Sagent Pharms, Dr Reddys Labs Ltd, and Sun Pharma Global. and is included in nineteen NDAs.

The generic ingredient in DOXORUBICIN HYDROCHLORIDE is doxorubicin hydrochloride. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the doxorubicin hydrochloride profile page.

Summary for Tradename: DOXORUBICIN HYDROCHLORIDE

Patents:0
Applicants:14
NDAs:19
Suppliers / Packagers: see list11
Bulk Api Vendors: see list76
Clinical Trials: see list3,460
Patent Applications: see list9,761
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXORUBICIN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: DOXORUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION208657-001May 15, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-001May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
doxorubicin hydrochloride
INJECTABLE, LIPOSOMAL;INJECTION208657-002May 15, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-002May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION200901-001Feb 14, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Federal Trade Commission
Cerilliant
Cipla
Chinese Patent Office
Johnson and Johnson
McKesson
Julphar
Deloitte
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot